KEOSF News Alert Kelso Technologies I (KEOSF) 5.0159 09/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kelso Technologies I (KEOSF) 5.0159 $KEOSF

Kelso Technologies Inc.: Financial Results for the Six Months Ended June 30, 2014
Marketwire - Wed Aug 06, 8:05AM CDT
Kelso Technologies Inc. (the "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) -

PHMSA/AAR/FRA-New Requirements for Rail Tank Cars
Marketwire - Tue Jul 29, 8:04AM CDT
Kelso Technologies Inc. (TSX: KLS)(OTCQX: KEOSF) - The Company reports that the Association of American Railroads (AAR); U.S. Pipeline and Hazardous Material Safety Administration (PHMSA); and the U.S. Federal Railroad Administration (FRA) has put forth new requirements recommended for rail tank cars used in the transport of dangerous goods. These requirements establish a minimum threshold for rail cars transporting dangerous goods, including petroleum crude oil and ethanol. It covers High Flammable Trains defined as trains with more than 20 tank cars carrying Packing Group I or II commodities.

Transport Canada-New Requirements for TC/DOT 111 Tank Cars
Marketwire - Wed Jul 23, 8:04AM CDT
Kelso Technologies Inc. (TSX: KLS)(OTCQX: KEOSF) - The Company reports that Transport Canada has put forth on July 2nd 2014, new requirements for TC/DOT-111 tank cars used in the transport of dangerous goods by rail by incorporating by reference the technical standard TP14877, Containers for the Transport of Dangerous Goods by Rail (CPC 1232). These requirements establish a minimum threshold for rail cars transporting dangerous goods, including petroleum crude oil and ethanol. This proposed amendment is provided for informal comment which means that it has not yet been published in the Canada Gazette.

Kelso Technologies Inc.: Grant of Option
Marketwire - Mon Jul 07, 12:32PM CDT
Kelso Technologies Inc. (the "Company" or "Kelso" (TSX: KLS)(OTCQX: KEOSF) -

Kelso Declares Annual Dividend
Marketwire - Wed Apr 02, 8:05AM CDT
Kelso Technologies Inc. (The "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) -

Kelso Technologies Inc.: Financial Results for the Year Ended December 31, 2013
Marketwire - Mon Mar 31, 8:05AM CDT
Kelso Technologies Inc. (the "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has released its audited financial statements and Management Discussion and Analysis for the year ended December 31, 2013.

Kelso Technologies Inc.: Business Development Alliance With SafeRack
Marketwire - Thu Mar 20, 8:03AM CDT
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has formed a strategic business and engineering alliance with SafeRack Loading Rack Technologies ("SafeRack" . The goal is to incorporate Kelso's one-bolt Kelso Klincher(R) Manway ("KKM" technology as an integral part of a new generation of high-capacity crude oil loading terminal systems designed and provided by SafeRack. SafeRack is the leading expert in crude oil and liquid natural gas loading terminal engineering, procurement and construction services for the railroad and trucking industry.

Kelso Technologies Inc.: New Patent-Dual Rating Pressure Relief Valve
Marketwire - Thu Feb 20, 8:04AM CST
Kelso Technologies Inc. (TSX VENTURE: KLS)(OTCQX: KEOSF) - The Company reports that it has filed a patent application for a new externally mounted dual rating pressure relief valve ("DPRV" design for use on new rail tank cars and retrofits of existing rail tank cars.

Kelso Ranked as 2014 TSX Venture 50(R) Company
Marketwire - Wed Feb 12, 11:08AM CST
Kelso Technologies Inc. (the "Company" or "Kelso" (TSX VENTURE: KLS)(OTCQX: KEOSF) -

Advanced Proteome Therapeutics Corp. (APC) Provides Update on Ongoing Activities
Marketwire - Thu Dec 19, 1:07PM CST
Advanced Proteome Therapeutics Corporation ("APC" or the "Company" (TSX VENTURE: APC) is pleased to announce that through calendar year 2013 the Company has been applying its enabling Foundation Trinity(TM) Technology to proteins targeted for the treatment of cancers. Advanced, targeted therapies are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future. APC's technology will enable not only therapy targeted for tumor cells, but also the delivery of combination therapy in a single, pure therapeutic agent. To achieve this, it has been the Company's intention to utilize a unique protein, not only as a delivery system to tumor cells, but also as a scaffold upon which to attach each anti-cancer entity to its own specific site on the protein surface - both key to efficient manufacturing and product development. What is more, the protein itself appears to possess immunotherapeutic properties. Immunotherapy is perhaps the most powerful current approach to cancer, and one of great commercial interest to the pharmaceutical industry. This vision, the unique nature of the protein, and the ability to apply its proprietary enabling chemical technology to modification of the protein, differentiate APC from the competition.

C5 Insight Lauded With Top Awards and Honors in 2013
GlobeNewswire - Wed Dec 18, 2:09PM CST
C5 Insight, a technology consulting firm that specializes in customizing and implementing multiple customer relationship management (CRM) and enterprise collaboration solutions, reports another year of award-winning growth and success.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading